Regulus Therapeutics
RGLS
#7200
Rank
โ‚น52.35 B
Marketcap
โ‚น756.19
Share price
0.00%
Change (1 day)
462.22%
Change (1 year)

Regulus Therapeutics (RGLS) - Total debt

Total debt on the balance sheet as of March 2025 : โ‚น0.12 Billion

According to Regulus Therapeutics's latest financial reports the company's total debt is โ‚น0.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Regulus Therapeutics - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น23.5 M-88.18%
2023-12-31โ‚น0.19 B-61.72%
2022-12-31โ‚น0.51 B-1.54%
2021-12-31โ‚น0.52 B55.11%
2020-12-31โ‚น0.34 B-67.39%
2019-12-31โ‚น1.04 B-9.98%
2018-12-31โ‚น1.15 B-8.6%
2017-12-31โ‚น1.26 B-5.77%
2016-12-31โ‚น1.34 B
2014-12-31โ‚น1.48 B112.8%
2013-12-31โ‚น0.69 B25.58%
2012-12-31โ‚น0.55 B4.89%
2011-12-31โ‚น0.52 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sanofi
SNY
โ‚น2.493 T 1,920,528.12%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น774.26 B 596,266.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.152 T 3,198,329.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น2.987 T 2,301,042.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น2.913 T 2,243,861.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚น1.79 B 1,279.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น116.94 B 89,977.80%๐Ÿ‡บ๐Ÿ‡ธ USA